Hughes syndrome and thrombosis: The debate goes on

Medicina Clinica

Volumn 118, Issue 3, 2002, Pages 97-98

  Ruiz Irastorza, Guillermo ^a,b   Khamashta, Munther A ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PROTHROMBIN; CARDIOLIPIN ANTIBODY;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE CLASSIFICATION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; PATHOGENESIS; PREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; IMMUNOLOGY; SYNDROME; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; HUMANS; SYNDROME; THROMBOSIS;

EID: 0037006381     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72297-5     Document Type: Editorial

References (22)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
2. Validation of the Sapporo criteria for antiphospholipid syndrome
3. 2-glycoprotein I antibodies
4. Autoantibodies against human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus
5. Antiphospholipid-protein antibodies and ischemic stroke: Not just cardiolipin anymore
6. Anticardiolipin testing
7. 2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome
8. Anticardiolipin antibodies are not an independent risk factor for stroke: An incident case-referent study nested within the MONICA and Vasterbotten cohort project
9. Diagnostic testing for coagulopathies in patients with ischemic stroke
10. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients
11. The management of thrombosis in the antiphospholipid-antibody syndrome
12. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis
13. Cerebrovascular ischemic events with high positive anticardiolipin antibodies
14. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis
15. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
16. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
17. Warfarin for multiple sclerosis?
18. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy
19. Guidelines on the investigation and management of the antiphospholipid syndrome
20. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: Analysis of a series of 66 patients treated with oral anticoagulation to a target INR of 3.5
21. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients
22. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies